Aβ-induced neurodegeneration is limited in APP and APP + PS1 transgenic mice. In middle-aged APP + PS1 transgenic mice, we found significantly increased Bcl-2 expression. The increase in Bcl-2 is restricted to amyloid-containing brain regions and is not found at young ages, suggesting that Aβ deposition is the stimulus for increased Bcl-2. Western blot results were confirmed with immunohistochemistry and qRT-PCR. In addition, we found that APP transgenic mice were protected from neurotoxicity caused by an injection of bak BH3 fusion peptides, known to induce apoptosis by antagonizing bcl protein activity. Nissl and fluorojade-stained slides showed that the active bak BH3 peptide caused substantial neuronal loss in the dentate gyrus and CA3 regions of nontransgenic, but not APP mice. The inactive mutant bak BH3 peptide did not cause degeneration in any mice. These data demonstrate that the increased Bcl-2 expression in brain regions containing Aβ deposits is associated with neuroprotection.
The amyloid cascade hypothesis states that the dysregulation of amyloid precursor protein (APP) processing and Aβ production are the major causes for neuronal death and dysfunction leading to dementia in Alzheimer's disease (Hardy and Selkoe, 2002) . Genetic and environmental factors, such as APP or PS-1 mutations, cause an accumulation of Aβ which forms diffuse and compact plaques. These plaques are thought to cause oxidative stress, activate microglia and astrocytes, causing cytokine release, inflammation and altered ionic homeostasis, culminating in cytotoxicity and neuronal death.
The Aβ peptide can directly induce neuronal apoptosis in vitro (Pike et al., 1993; Hensley et al., 1995; Schubert and Chevion, 1995; Wogulis et al., 2005) . Intracellular Aβ may activate apoptosis by interacting with the endoplasmic reticulum and endosomes and by binding to alcohol dehydrogenase within the mitochondria (Dickson, 2004) . Aβ also induces changes in nitric oxide production and mitochondrial activity facilitating apoptosis (Keil et al., 2004) . In vitro studies have shown that Aβ provokes a significant downregulation of antiapoptotic proteins such as Bcl-2, Bcl-xl and Bcl-w and a significant up regulation of proapoptotic proteins such as bax (Yao et al., 2005) .
Aβ-induced neuronal toxicity is limited in the APP transgenic mouse models of AD. A modest reduction in hippocampal neurons was found in old APP23 mice, but the cortical neuron census was unaffected despite extensive amyloid deposition (Calhoun et al., 1999) . Several attempts in the Tg2576 and PDAPP lines have failed to detect significant changes in neuron number with amyloid deposition (Irizarry et al., 1997b (Irizarry et al., , 1997a Takeuchi et al., 2000) . Given the established toxicity of Aβ to cultured neurons, the lack of neuronal death in APP overexpressing mice has been perplexing.
Bcl-2 is the prototypical antiapoptotic member of a large family of proteins involved in the modulation of cell death (Chao and Korsmeyer, 1998) . The members of the Bcl-2 family possess sequence homology in several regions termed BH1, BH2, BH3 and BH4. The BH1-3 domains form a cleft that acts as a binding region for the BH3 domain of another protein member of the Bcl-2 family, thus allowing the formation of homodimers or heterodimers. Depending on the proteins involved, dimerization may cause cell survival or cell death. An effort to antagonize the antiapoptotic action of Bcl-2 like proteins led to the development of synthetic BH3-like peptides that bind the BH1-3 domain cleft of Bcl-2 proteins, thus inhibiting the dimerization of Bcl-2 to proapoptotic members of the Bcl family such as Bax or Bak (Zong et al., 2001; Polster et al., 2001; Kaufmann et al., 2001) . Fusion of the BH3 domain from Bak with the internalization domain of the Antennapedia homeodomain protein permits penetration of the BH3 domain through cell membranes (Holinger et al., 1999) . If antiapoptotic Bcl-
